Clinical pharmacology and human antitumor activity of cytosine arabinoside
- 1 January 1967
- Vol. 20 (5) , 809-816
- https://doi.org/10.1002/1097-0142(1967)20:5<809::aid-cncr2820200536>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Isolation and antileukemic activity, in mice, of 1-β-d-arabinofuranosylcytosine 5′-phosphate present in synthetic 5′-cytidylic acidBiochemical Pharmacology, 1966
- The effects of 1-β-d-arabinofuranosylcyto-sine on the developing chick embyroBiochemical Pharmacology, 1966
- Biochemical and pharmacological studies with 1-β-d-arabinofuranosylcytosine in manBiochemical Pharmacology, 1966
- Studies of the enzymatic deamination of cytosine arabinoside—IBiochemical Pharmacology, 1965
- The Induction of Chromatid Lesions by Cytosine Arabinoside in Post-DNA-Synthetic Human LeukocytesCytogenetic and Genome Research, 1965
- Posterior Fossa AneurysmsNeurosurgery, 1965
- The reversal of cytosine arabinoside activity in vivo by deoxycytidineBiochemical Pharmacology, 1964
- Cell Culture Studies on Antiviral Agents: I. Action of Cytosine Arabinoside and Some Comparisons with 5-Iodo-2-Deoxyuridine.Experimental Biology and Medicine, 1964
- A proposed mechanism of action of 1-β-d-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cellsBiochemical Pharmacology, 1962
- Antitumor Activity of 1- -D-Arabinofuranosylcytosine HydrochlorideExperimental Biology and Medicine, 1961